FEATURED CONTRIBUTED CONTENT
As pharmaceutical, biotechnology, and medical device industries continue to evolve to meet growing pressures to bring life-enhancing pharmaceuticals, biologics, and devices to market in a timely, cost-efficient, and safe manner, sponsors will need to rely on the global and integrated services of world-class CROs that have the experts on staff to align strategic objectives as […]
Michael Pollock and Mark Cziraky discuss how their two companies’ recent collaboration and combined strengths will improve real-world outcomes/evidence and Phase IV pragmatic trials.
Clinical Research Management, Inc. (ClinicalRM) has recently launched several clinical trials in West Africa. By evaluating the safety and efficacy of Ebola convalescent plasma for the treatment of Ebola virus disease and large vaccine studies in the hot zone, the Ohio-based contract research organization (CRO) has reached a milestone year in global development and expansion. […]
Gregory Skalicky discusses the evolution of strategic engagements with sponsors and the benefits of working with a full-service, global CRO.
Putting Volunteers First: What Every Clinical Team Should Consider Before Developing the Next Protocol
Only about 5 percent of those eligible to participate in trials actually do so, even though the number and size of studies have been escalating. Those who do volunteer to participate in trials can face some frustrating experiences, thanks to what could be characterized as a combination of faulty communication and protocol missteps. Among them: […]
Lynn King shares some misconceptions about risk-based monitoring and offers alternative clinical monitoring strategies using RBM.
Joseph Sgherza outlines global trends related to clinical trials for pandemic responses, innovations in logistics, and how ClinicalRM assists in pandemic situations.
Dr. Hurley discusses regulatory challenges in an era of mergers and acquisitions, FDA review practices, and managing the FDA approval process.
Abhishek Shankar discusses the value of patient-centricity and and how the cloud is transforming operations in the life-sciences industry.
Bonnie Brescia and Claire Meunier talk about integrating the patient voice in clinical research, and how wearables, ingestibles, and other technologies are supporting patient centricity.
Jim Nichols provides an overview of structured content management (SCM) and why it’s important; he also shares examples and metrics of projects and outlines the next step in the evolution of SCM.
Michelle Petersen discusses why rare disease and orphan indications are unique, related challenges to development, and tips for common study execution.
In this episode, Ms. Gartman discusses the findings from their recent research on Patient Advocacy Groups and their relationship with pharmaceutical companies. There is also a related white paper on this topic, now availablTe for download.
David Burnham explores ways to improve the CRO-sponsor relationship and the associated benefits of a partnership alliance and successful strategic CRO-sponsor collaboration.
Oral treatments are transforming cancer care, moving the administration of treatment from the hospital to the patient’s home. This is shifting the responsibility for managing medications from healthcare professionals to patients, making adherence an important consideration in the oncology field.
Andrew Townshend outlines the key benefits of a strategic CRO-sponsor alliance and ways to maximize the expertise from one project to the next.
[This is a guest blog post by Jean McCoy, SVP, Strategy & Innovation, Health Advocacy Strategies] There’s no way around it: health challenges are emotional. Dealing with the ways our bodies seem to turn against us, both large and small, can be all-consuming, and most of us turn to trusted sources to help sort through our emotional […]
Claims data highlight a portion of script abandonment, but don’t capture patients who never get to the pharmacy. Zitter Health Insights’ new and innovative research on script abandonment not only captures all types of abandonment, including before patients even get to the pharmacy, but also provides you with the “why.” How often is abandonment mindful […]
Bonnie Brescia and Christel Aprigliano discuss the past, present, and future of patient centricity.
Drs. Pritchard and Chee discuss Celerion’s expansion into South Korea, KoNECT’s role in fostering clinical research in South Korea, and the advantages of conducting clinical research in South Korea.
Dr. Spector describes how the R&D model will change by 2025, the void in clinical research talent, and preparing for the future.
David Laky provides an overview on integrated solutions in clinical development systems and their impact on the future of clinical research.
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we will discuss these five best practices for life science companies to deliver effective multichannel experiences: 1. Ensuring reliable customer data 2. Aligning communication channels 3. Creating a high-leverage content strategy 4. […]
Dramatic changes in U.S. healthcare over the last few years have forced a rethinking of the partnerships pharmaceutical companies form with groups representing patients and families. inVentiv Health Public Relations Group interviewed dozens of patient advocacy organizations and patient advocates to understand how they view the changes and what they seek from their pharma partners.
Bill Cooney discusses how studies are becoming digital, how this impacts clinical research subjects, and how the industry needs to adapt.
A White Paper discussing the benefits and key considerations behind implementing a mobile strategy for patient data capture in clinical research, as well as analysing how the use of mobile COA solutions (eCOA) can overcome practical challenges of capturing PRO measures through better quality, reliability, integrity and traceability of the collected data. The paper is […]